MarketInOut Stock Screener Log In | Sign Up
 

Gennex Laboratories Ltd

BSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 08/14/2026
Gennex Laboratories Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeBSE
Market Capitalization2,320.15 mln
Float170 mln

EPS

0.76
Decent

P / E

14.21
Fair value

Piotroski F-Score

3 / 9
Below average

Beneish M-Score

-1.33
Manipulation likely

Relative Strength

96 / 100
Top performer

Debt / Equity

0.36
Low leverage

Business Description

Founded in 1985 and headquartered in Hyderabad, India, Gennex Laboratories Limited is a pharmaceutical company that produces and distributes active drug ingredients and biotechnology products. The company's portfolio covers a wide range of medical needs, including treatments for respiratory conditions, muscle pain, allergies, urinary tract discomfort, fungal infections, depression, and gout. Gennex sells its products across more than 20 countries spanning Asia, Europe, Latin America, and the Middle East. The company was originally known as Prudential Pharmaceuticals Limited before adopting its current name in September 2007.

Key Fundamentals

EPS0.76
P/E14.21
ROE9.51
RPS6.73
ROIC10.52
ROA6.16
Interest Cover5.82
EBITDA, mln304
EV / EBITDA4.76
EV / EBIT5.22
Revenue, mln1,727
EV / Revenue0.84

Financial Strength

Altman Z-Score2.56
Piotroski F-Score 3 / 9
Beneish M-Score-1.33
Price to Lynch Fair Value0.48
Price to Graham Number0.75
Shiller PE Ratio22.64

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 20.67% 98 / 100   
1 Month 19.34% 92 / 100   
2 Months 7.57% 69 / 100   
6 Months -13.18% 27 / 100   
1 Year -15.62% 45 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us